News

And other biotech news brought to you by The Readout.
NEW YORK – The UK's National Institute for Health and Care Excellence on Thursday issued two final guidances, in which it recommended against making Eisai and Biogen's Leqembi (lecanemab) and Eli ...
Note that some links may require registration or subscription. Three people died and 16 have been hospitalized in a listeria ...
Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...
Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...
New da­ta on an in­jectable form of Ei­sai’s Alzheimer’s drug, Leqem­bi, showed that it was more ef­fec­tive than an in­tra­venous ver­sion at clear­ing amy­loid but … ...
TAIPEI (Taiwan News) — Far Eastern Memorial Hospital is set to become the first medical institution in Taiwan to administer ...